DEPO finds wings, C mushrooms, CHMP anything but champ

Depomed Inc. (Nasdaq: DEPO) shares gained 30 percent to $8.11, on volume of 5.5 million shares, more than five times what it would trade during an average day, after the drug developer said late Friday that regulators approved its marketing of its treatment for shingles.

Citigroup Inc. (NYSE: C) held its usual place atop the volume ladder Monday, trading in 95.2 million shares. Its daily volume averages around 551 million. Share prices were up 1.4 percent at $4.76, after a portfolio manager for the Artio Global Equity Fund said the run in C shares is far from over.

Champion Industries Inc. (Nasdaq: CHMP) lost a bit of its grip early Monday, tumbling 7.8 percent to $1.78, on volume of 30,111 or nearly twice its full-day average, only days after reporting better results for 2010’s full year and last quarter. The West Virginia-based company announced net income of $0.5 million or $0.05 per share on a basic and diluted basis for the year ended October 31, 2010 compared to a net loss of $(27.5) million or $(2.76) per share on a basic and diluted basis for the year ended October 31, 2009.

Tags: buzz stocks, C, CHMP, DEPO, Financial Stocks, healthcare, nasdaq, NYSE

This entry was posted on Monday, January 31st, 2011 at 11:13 am by Glenn and is filed under Financial Stocks, Health Care Stocks. You can follow any responses to this entry through the RSS 2.0 feed. You can leave a response, or trackback from your own site.